Adult
PO
Parkinsonism. Initial: 125 mg twice daily, increase at 3-4 day intervals if needed. Max: 8 g/day.
When used with benserazide:
- levodopa-naive patients. Initial: 50 mg 3-4 times/day (advanced stage: 100 mg 3 times/day), increase as directed. Maintenance: 400-800 mg/day in divided doses.
- patients previously on levodopa monotherapy: 10-15% of previous usual dose.
- patients previously on other levodopa/dopa-decarboxylase combination therapy. Initial: 50 mg 3-4 times/day.
When used with carbidopa:
- levodopa-naive patients. Initial: 100 mg 3 times/day, increase as directed. Maintenance: 0.75-2 g/day in divided doses.
- patients previously on levodopa monotherapy: 20-25% of the dose previously taken 3 or 4 times daily.
- patients previously on other levodopa/dopa-decarboxylase combination therapy: initial dose should provide the same daily levodopa dose.
Adverse drug reactions: GI disturbances, orthostatic hypotension, cardiac arrhythmias, depression, dyskinesias, delirium, hallucinations.
Adapted from CIMS Drug Information System. Internet. Accessed on January 10, 2016.